Peter Feinberg is Director at Immuneering Corp (IMRX). They have made 11 open-market trades across 1 company since 2021, most recently 2026-01-12.
CIK 0001870076
11 open-market purchases totalling $3.7M since 2021, never a sale. Across 11 scored buys the stock is up 11.3% at ninety days, and 8.7 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMRX | 135,441 | $487K |
| NTBL | 40,247 | $10K |
| Total | $497K |
Shares reported on the most recent Form 4, priced at the 2026-01-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 45% | 45% |
| Avg Move | +5.3% | -0.8% | +11.3% |
| Alpha | +4.7% | -1.6% | +8.7% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2026-01-12 | 2026-01-14 | $4.35 | $87K | +17.3% | +10.5% | +20.9% |
| IMRX | BUY | 2025-10-03 | 2025-10-07 | $6.67 | $50K | -10.6% | +6.1% | +5.9% |
| IMRX | BUY | 2025-09-30 | 2025-10-01 | $7.03 | $53K | -7.5% | +3.5% | +1.4% |
| IMRX | BUY | 2025-09-29 | 2025-09-30 | $7.18 | $36K | -12.1% | -8.0% | -4.4% |
| IMRX | BUY | 2025-06-18 | 2025-06-23 | $2.53 | $127K | +35.3% | +60.8% | +242.4% |
| IMRX | BUY | 2024-03-22 | 2024-03-25 | $2.55 | $128K | -13.1% | -40.5% | -40.9% |
| IMRX | BUY | 2024-03-18 | 2024-03-19 | $2.39 | $287K | -1.4% | -36.6% | -45.0% |
| IMRX | BUY | 2022-03-15 | 2022-03-16 | $6.75 | $45K | -1.0% | -10.0% | -33.8% |
| IMRX | BUY | 2021-09-20 | 2021-09-21 | $24.45 | $232K | +5.1% | -5.0% | -23.7% |
| IMRX | BUY | 2021-09-13 | 2021-09-15 | $21.50 | $255K | +15.8% | -12.3% | -24.3% |
| IMRX | BUY | 2021-08-03 | 2021-08-04 | $15.00 | $2.4M | +30.0% | +22.9% | +25.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.